% | $
Quotes you view appear here for quick access.

Array BioPharma Inc. Message Board

  • urabt2 urabt2 Nov 26, 2013 12:04 PM Flag

    Steadily downward trend for a week....

    Without news, I am guessing that the company is planning on raising equity and some big mouth bankers are leaking it and driving the SP down ahead of it. I surely hope that I am wrong and wish that these companies would just use the Celldex/Canter Fitzgerald startegy of selling shares quietly on an ongoing non-underwritten basis when the share price is over a certain threshold (say $5.70 for ARRY).

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • burnaka Nov 26, 2013 2:27 PM Flag

      They do have an automatic sale of stock in place, not sure of price restrictions etc., but there are still plenty of shares in the ATM program. No secondary for at least 18 months at current cash burn rate, and they might just renew the ATM program down the road. Funds are stealing shares from the average investor creating frustration holding this dog. I think it stays weak until DEC., and we see no real price move unless a buy out is announced. The real catalysts, phase 3 results, and drug approvals are a few years out. So the stark reality here is Arry is a dead money hold for no less than 2 years, or a buy out, HOPE I am wrong but that is picture painted here.

    • Well a CTO was filed yesterday, MM's could be bring the price down before a new partnership announcement and run up

3.56+0.07(+2.01%)Jun 30 4:00 PMEDT